Market closedNon-fractional
Vericel/VCEL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Vericel
Ticker
VCEL
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Cambridge, United States
Employees
-
Website
vcel.com
Vericel Metrics
BasicAdvanced
$2.5B
Market cap
6185.69
P/E ratio
$0.01
EPS
1.70
Beta
-
Dividend rate
Price and volume
Market cap
$2.5B
Beta
1.7
Financial strength
Current ratio
5.202
Quick ratio
4.403
Long term debt to equity
36.829
Total debt to equity
39.399
Interest coverage (TTM)
-6.17%
Management effectiveness
Return on assets (TTM)
-0.75%
Return on equity (TTM)
0.21%
Valuation
Price to earnings (TTM)
6,185.69
Price to revenue (TTM)
11.888
Price to book
10.63
Price to tangible book (TTM)
10.95
Price to free cash flow (TTM)
1,213.245
Growth
Revenue change (TTM)
22.72%
Earnings per share change (TTM)
-102.31%
3-year revenue growth (CAGR)
16.31%
3-year earnings per share growth (CAGR)
-54.87%
What the Analysts think about Vericel
Analyst Ratings
Majority rating from 6 analysts.
Vericel Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$51M
-21.11%
Net income
-$3.8M
-129.46%
Profit margin
-7.42%
-137.34%
Vericel Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.11
-$0.08
$0.26
-$0.08
-
Expected
-$0.15
-$0.12
$0.17
-$0.11
-$0.09
Surprise
-27.54%
-34.52%
52.64%
-27.16%
-
Vericel News
AllArticlesVideos
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
GlobeNewsWire·5 days ago
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
GlobeNewsWire·1 week ago
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vericel stock?
Vericel (VCEL) has a market cap of $2.5B as of July 27, 2024.
What is the P/E ratio for Vericel stock?
The price to earnings (P/E) ratio for Vericel (VCEL) stock is 6185.69 as of July 27, 2024.
Does Vericel stock pay dividends?
No, Vericel (VCEL) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Vericel dividend payment date?
Vericel (VCEL) stock does not pay dividends to its shareholders.
What is the beta indicator for Vericel?
Vericel (VCEL) has a beta rating of 1.7. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Vericel stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.